We are live on ! Find out more
RDHL

Redhill Biopharma
RDHL

17 hedge funds and large institutions have $450K invested in Redhill Biopharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

0% more funds holding

Funds holding: 17 → 17 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

42% less capital invested

Capital invested by funds: $782K → $450K (-$332K)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
2
Closed
5
Calls
$24K
Puts
–
Net Calls
+$24K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$70.8K
2
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
+$52.1K
3
GS
Gagnon Securities
New York
+$34K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$26K
5
Squarepoint
Squarepoint
New York
+$8.94K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$369K
2
SM
Sabby Management
Florida
-$324K
3
Citadel Advisors
Citadel Advisors
Florida
-$28.4K
4
TSS
Two Sigma Securities
New York
-$12.9K
5
VF
Virtu Financial
New York
-$10K
Name Holding Trade Value Shares
Change 		Change in
Stake
GS
1
Gagnon Securities
New York
$131K +$34K +1,665 +87%
Jane Street
2
Jane Street
New York
$126K +$70.8K +3,472 New
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Quebec, Canada
$99.6K +$52.1K +2,552 +1,450%
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$50.9K +$26K +1,273 +1,052%
MOS
5
MGO One Seven
Ohio
$23K – – –
Squarepoint
6
Squarepoint
New York
$16K +$8.94K +438 New
Morgan Stanley
7
Morgan Stanley
New York
$1.68K +$612 +30 +188%
Group One Trading
8
Group One Trading
Illinois
$898 – – –
APC
9
Aspire Private Capital
North Carolina
$592 +$326 +16 New
SPIA
10
Steward Partners Investment Advisory
New York
$183 – – –
Citigroup
11
Citigroup
New York
$166 +$102 +5 New
Osaic Holdings
12
Osaic Holdings
Arizona
$152 -$20 -1 -20%
UBS Group
13
UBS Group
Switzerland
$152 +$20 +1 +33%
Bank of America
14
Bank of America
North Carolina
$120 +$41 +2 +200%
AEPWM
15
Atlantic Edge Private Wealth Management
Florida
$37 +$20 +1 New
Wells Fargo
16
Wells Fargo
California
$34 – – –
JP Morgan Chase
17
JP Morgan Chase
New York
$12 – – –
IA
18
IFP Advisors
Florida
$10 – – –
AC
19
Armistice Capital
New York
– -$369K -28,916 Closed
SM
20
Sabby Management
Florida
– -$324K -25,400 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$28.4K -2,231 Closed
TSS
22
Two Sigma Securities
New York
– -$12.9K -1,015 Closed
VF
23
Virtu Financial
New York
– -$10K -795 Closed
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
– -$1.71K -84 -93%

RDHL Hedge Fund Activity: Q4 2023 in Review

17 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q4 2023, worth a combined $450K — down 42% from $782K a quarter earlier.

Fund positioning in RDHL was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 2 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $70.8K. The largest seller was Armistice Capital, exiting entirely with an estimated $369K sold.

  • 17 institutional investors held Redhill Biopharma (RDHL) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $450K of Redhill Biopharma stock for Q4 2023, down 42% quarter-over-quarter.
  • 5 funds opened new Redhill Biopharma positions in Q4 2023 and 5 closed out, a net change of 0 holders.
  • The largest Redhill Biopharma buyer in Q4 2023 was Jane Street, an estimated $70.8K added.
  • The largest Redhill Biopharma seller in Q4 2023 was Armistice Capital, an estimated $369K sold.

Based on aggregated 13F filings for Q4 2023.